The saddest thing about Jake White’s departure is that no one much cares in Montpellier. As this column reported in May, the former Springbok coach has never courted the affection of the locals. Big mistake. White isn’t the first Anglophone coach to fail in France, and he won’t be the last, but that a man of his experience should have so utterly misread the French psyche suggests stubbornness or vanity got the better of him.It went wrong from just about the first moment White arrived at the club in January 2015 and made an ill-judged joke about Montauban. Then he fired a lot of French players, hired a lot of South African players and got them playing a style of rugby that bored Montpellerians to tears.I know Montpellier well. I lived there for five years. Played rugby, bought a house, raised a child. I was one of them. In as much as a Brit ever could be. They’re a hot-blooded lot in the Languedoc.Unlike other cities on the Mediterranean coast – Narbonne, Beziers, Perpignan and Toulon – Montpellier isn’t steeped in rugby history. It’s more of a football city by nature, and rugby only really began to take hold a decade ago when the club moved to a new stadium and fielded four talented local lads in Louis Picamoles, Julien Thomas, Fulgence Ouedraogo and Francois Trinh-Duc.Hands off! Montpellier flanker Fulgence Ouedraogo takes on Pau. Photo: Getty ImagesThe appointment of Fabien Galthié as coach in 2010 only made the club sexier in the eyes of the fans. A native of Cahors, a couple of hundred miles north of Montpellier, Galthié had the same volatile temperament as them.Attendances rose. In the first four matches of the 2013-14 season the average gate was 13,276 and president Mohed Altrad began to dream of building a club to rival Mourad Boudjellal’s Toulon. But then he and Galthié fell out. Word has it that the former France captain is a brilliant technician but a hopeless people person. As he started to lose the dressing room Galthié swanned off to Brazil for a birthday party when he should have been preparing his team to play Oyonnax.Altrad showed Galthié the door and brought in as his successor a man as gruff as Galthié was garrulous. White doesn’t use two words where one will do, but however many he used none were French. According to the French press, White’s failure to learn the language to any significant degree was a contributory factor in Altrad’s decision not to extend his contact.Moving on: Scotland coach Vern Cotter is expected to take over at Montpellier in June. Photo: Getty ImagesWhite wanted to stay on, says L’Equipe, but his president wants him out when his contract expires in June. Tuesday’s paper states that Altrad has been searching for a successor since the summer, allegedly offering Bernard Laporte a monthly salary of €100,000 if he took the job. The former Toulon coach turned it down; his focus remains on the FFR presidency. In the end Altrad has hired Vern Cotter on a three-year deal, with the Kiwi taking up his position next June. South African Jake White is set to be replaced as Montpellier coach by Vern Cotter next summer – here’s a look at where he went wrong These are a passionate people. Proud and emotional. And sentimental, though it’s unlikely much of that will be wasted on White when he leaves.For the latest Rugby World subscription offers, click here. Watchful eye: Montpellier head coach Jake White oversees training. Photo: Getty Images LATEST RUGBY WORLD MAGAZINE SUBSCRIPTION DEALS White was doomed, claims L’Equipe, from the day last November when he allegedly sounded out the RFU about the vacant England job. Montpellier were in London to play Harlequins in the European Challenge Cup and apparently the South African let it be known he was interested. Altrad wasn’t impressed.But is there more to it than that? After all, White is an ambitious international coach, and it’s only natural that he’d express a mild interest in one of the top coaching jobs in world rugby.Euro winners: Montpellier celebrate beating Harlequins to lift the Challenge Cup last season. Photo: Getty ImagesMight not the fact that crowd numbers are on the wane have also alarmed Altrad? The average gate this season is 10,431, nearly 3,000 fewer than three years ago. Yet this is a club that last season won the Challenge Cup and reached the semi-finals of the Top 14. Fans should be flocking to cheer on their boys. But the locals don’t want to cheer for a team of South Africans, the ‘Langueboks’, as they’ve been dubbed. Of the 39 players listed on the Montpellier website, 18 are French.Only Ouedraogo remains of that youthful quartet from a decade ago. In the summer Trinh-Duc departed to Toulon after 13 years of loyal service. There was no fond farewell for Trinh-Duc from his adoring public. White wouldn’t allow him that honour. Instead, in a spiteful gesture he dropped Trinh-Duc from the squad for the final home match of the season. Asked why by a baffled French press, a scornful White explained that professional rugby was no place for sentiment.In a sense he’s right but sentiment matters to the French. Anachronistic, maybe, in 21st century sport, but that’s the way the French are. Trouble is, White never bothered to learn much about the French. He was too busy getting his team to play a style of rugby that was clinical and cold-blooded. Everything the city of Montpellier is not.
Local NewsBusiness Twitter TAGS Pinterest Facebook Twitter Pinterest LA JOLLA, Calif.–(BUSINESS WIRE)–Jan 28, 2021– DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its support and presentation in the Melanoma Research Foundation’s (“MRF”) “Ask the Expert” webinar series throughout the month of January. The events featured leading dermatologists and industry experts to increase awareness and education on melanoma. A key focus of the series was the importance of early detection of skin cancer and the delays in skin cancer screenings and diagnosis resulting from the COVID-19 pandemic. The recorded webinars are accessible here. The “Ask the Expert” webinars took place on the MRF Facebook page with the following speakers:Jan. 7, 2021: Dr. Neal Bhatia, Therapeutics Clinical Research.Jan. 14, 2021: Dr. Ann Mazor Reed, Rendon Center Dermatology & Aesthetic Medicine and Skin Care Research.Jan. 21, 2021: Dr. Stephanie Diamond, Advanced Dermatology and Dr. Chris Adigun, Dermatology & Laser Center of Chapel Hill.Jan. 28, 2021: Dr. Julie Karen, Complete Skin MD and New York University Langone Medical Center. “Education, early detection and prevention are some of the most powerful tools to fight melanoma,” said Burkhard Jansen, M.D., chief medical officer of DermTech. “We are proud to support the MRF and its ‘Ask the Expert’ sessions in raising awareness of this aggressive form of skin cancer.” “This informative series is a vital element to preventing melanoma in as many people as possible,” said Kyleigh LiPira, MBA, chief executive officer of the MRF. “Our work with DermTech complements our mission of providing the necessary insight and resources to vigilantly prevent and detect melanoma. We are excited to kick off 2021 with new sessions and conversations.” For more information on the “Ask the Expert” Facebook Live webinars, including additional upcoming topics for discussion, please visit the MRF Facebook page here. About DermTech DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by our non-invasive skin genomics platform. DermTech’s mission is to transform dermatology with our non-invasive skin genomics platform, to democratize access to high quality dermatology care, and to improve the lives of millions. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early detection of skin cancers, and is developing products that assess inflammatory diseases and customize drug treatments. For additional information on DermTech, please visit DermTech’s investor relations site at: www.DermTech.com. Forward-looking Statements This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of DermTech may differ from its actual results and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, expectations with respect to: the performance, patient benefits, cost-effectiveness, commercialization and adoption of DermTech’s products, including the Smart Sticker platform, and the market opportunity therefor. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside of the control of DermTech and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the outcome of any legal proceedings that may be instituted against DermTech; (2) DermTech’s ability to obtain additional funding to develop and market its products; (3) the existence of favorable or unfavorable clinical guidelines for DermTech’s tests; (4) the reimbursement of DermTech’s tests by Medicare and private payors; (5) the ability of patients or healthcare providers to obtain coverage of or sufficient reimbursement for DermTech’s products; (6) DermTech’s ability to grow, manage growth and retain its key employees; (7) changes in applicable laws or regulations; (8) the market adoption and demand for DermTech’s products and services together with the possibility that DermTech may be adversely affected by other economic, business, and/or competitive factors; and (9) other risks and uncertainties included in (x) the “Risk Factors” section of the most recent Quarterly Report on Form 10-Q filed by DermTech with the Securities and Exchange Commission (the “SEC”), and (y) other documents filed or to be filed by DermTech with the SEC. DermTech cautions that the foregoing list of factors is not exclusive. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. DermTech does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based. View source version on businesswire.com:https://www.businesswire.com/news/home/20210128005964/en/ CONTACT: DermTech Sarah Dion [email protected] 858.450.4222 Crowe PR Sarah Gallagher [email protected] 224.406.4709 Melanoma Research Foundation Lorrie Beth Miley [email protected] 202.742.5913 KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH MEDICAL DEVICES HEALTH ONCOLOGY SOURCE: DermTech, Inc. Copyright Business Wire 2021. PUB: 01/28/2021 04:30 PM/DISC: 01/28/2021 04:30 PM http://www.businesswire.com/news/home/20210128005964/en WhatsApp By Digital AIM Web Support – January 28, 2021 WhatsApp DermTech Featured in Melanoma Research Foundation Weekly “Ask the Expert” Facebook Live Events Alongside Notable Industry Scientists Facebook Previous articleSonoma Pharmaceuticals and Microderm Technologies Announce that Dermodacyn® Disinfecting Solution is Now Available in Hong Kong and ThailandNext articleVoya Financial Declares Common and Preferred Stock Dividends Digital AIM Web Support